Page last updated: 2024-11-06

amflutizole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

amflutizole: xanthine oxidase inhibitor; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54833
CHEMBL ID2106558
SCHEMBL ID395613
MeSH IDM0135317

Synonyms (31)

Synonym
amflutizolum [latin]
4-amino-3-(alpha,alpha,alpha-trifluoro-m-tolyl)-5-isothiazolecarboxylic acid
amflutizole [usan:inn]
5-isothiazolecarboxylic acid, 4-amino-3-(3-(trifluoromethyl)phenyl)-
ly 141894
4-amino-3-(3-(trifluoromethyl)phenyl)-5-isothiazolecarboxylic acid
amflutizole
amflutizol [spanish]
amflutizole (usan/inn)
D02896
82114-19-0
4-amino-3-[3-(trifluoromethyl)phenyl]-1,2-thiazole-5-carboxylic acid
amflutizol
unii-83n680m457
amflutizolum
83n680m457 ,
ly-141894
CHEMBL2106558
5-isothiazolecarboxylicacid, 4-amino-3-[3-(trifluoromethyl)phenyl]-
AKOS014999830
amflutizole [usan]
amflutizole [inn]
4-amino-3-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-5-isothiazolecarboxylic acid
3-(3-trifluoromethylphenyl)-4-amino-5-isothiazolecarboxylic acid
SCHEMBL395613
Q4745983
4-amino-3-(3-(trifluoromethyl)phenyl)isothiazole-5-carboxylic acid
DTXSID00868642
EN300-255085
4-amino-3-(3-(trifluoromethyl)phenyl)isothiazole-5-carboxylicacid
Z1267786595
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's5 (71.43)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]